StockWatch
·
IDEAFORGE TECHNOLOGY LTD · QQ2 FY-2027 · THE CALL

Record growth, order book replenishment uncertain

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsIDEAFORGEIdeaforge Technology Ltd11 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Gross margin guidance (50-55%) tracked; order book execution pace slower than Q1 implied 'by Q3'. No guidance explicitly withdrawn.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong Q2 execution (₹91.3 Cr revenue, +124% YoY, return to ₹6.5 Cr PAT) and gross margin expansion to 54.3% validate technology and execution capabilities. However, order book declined 21% QoQ to ₹202.2 Cr despite prior guidance implying ₹256.8 Cr execution by Q3, signaling slower-than-expected new order conversions. Large ₹20,000+ Cr fast-track procurement pipeline remains in early approval stages with no firm timelines; absence of forward guidance limits conviction.

₹91.3 Cr

Revenue · +124% YoY

₹6.5 Cr

Reported PAT · +132.9% YoY

Expanding

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Defense deliveries drove gross margin expansion from 50% to 54.3%

MET

Gross margin 54.3% vs 50% YoY; product mix shift confirmed but no segment breakdown

Executed >50% of FY'27 opening order book in H1

OVERSTATED

Order book fell ₹256.8 Cr to ₹202.2 Cr; H1 execution ~₹54.6 Cr (~45-47% if opening was ~₹340 Cr)

₹20,000 Cr fast-track procurement opportunities expected to accelerate Q3-Q4 orders

Unverified

Opportunities in evaluation/RFP stage; DAC cleared ₹2.12L Cr proposals; no conversions yet this quarter

Return to profitability at PAT level

MET

Q2 FY26 PAT loss ₹19.6 Cr; Q2 FY27 profit ₹6.5 Cr; YoY +132.9%

Order book replenishment is key priority alongside execution

MET

Order book declined 21% QoQ from ₹256.8 Cr to ₹202.2 Cr; new orders critical to sustain growth

Earnings quality

What changed since the last call

Deltas vs. the prior call

Order book trajectory softened

Downgrade

₹256.8 Cr at Q1 declined to ₹202.2 Cr after Q2 execution; implies full-year delivery, not 'by Q3' as prior guidance suggested

Gross margin expanded; product mix shifted

Upgrade

Q2 gross margin 54.3% vs 50% YoY; management attributes to defense mix; Q1 was 49%, suggesting sequential ₹5.3pp improvement

ZOLT Hybrid development formalized

New

Upgraded from ISR platform to combat-capable hybrid with 100-200km endurance; field trials ongoing; scale-up timeline extends into FY28

RDI funding secured for YETI

New

₹151 Cr matching principal grant + ₹150 Cr debt from Technology Development Board at 4% interest; formalizes YETI as strategic multi-year investment

US JV strategy reset

Withdrawn

First Breach JV agreement terminated (not operationalized, no capital deployed); pursuing US market independently via subsidiary and partnerships

The Q&A

Analysts pressed management on FTP quantum and timeline; management hedged citing approval dependencies. Questions on product mix, ZOLT variants, and order inflows went largely unanswered with specificity. Tone suggests analysts skeptical of FTP materialization in FY27; management defended execution track record but could not quantify near-term order conversion.

The exchanges that mattered

RDI funding terms — Abhijeet Singh, Systematix

Answered

Matching principal grant structure; company contributes equally. Debt is ~10-year tenure at 4% interest. Deployment split: debt repayment, R&D, working capital, capex.

Revenue drivers — Abhijeet Singh, Systematix

Partial

Defense deliveries were heaviest; cannot disclose specific product mix due to confidentiality; all platforms contributing.

ZOLT specification — Abhijeet Singh, Systematix

Answered

Target 100-200km endurance; early flight test phase; engineering data collection ongoing; expect dev cycle to extend into FY28 before production phase.

FTP pipeline clarity — Dipen Vakil, PhillipCapital

Dodged

Fragmented opportunities; some RFPs already released, others coming; timeline depends on approval cycle (varies 6 months to a year). No specific visibility.

Order book execution — Deepak Poddar, Sapphire

Partial

Most will execute H2, dependent on spare supplies. New orders expected Q3-Q4 bidding cycle. Cannot ballpark inflows yet.

Combat UAV capability — Nikhil Gupta, Vaayu

Answered

Mixed strategy: partner with mature solutions, develop own where technology advantage exists. ZOLT expanding into air-launched effects, integrated with ISR.

International markets — Tushar Khurana, Peace Wealth

Answered

NATO opportunities pursued; Middle East expansion active (Raisina visit); US: JV terminated, pursuing independently via subsidiary and partnerships; Blue SUAS certification ongoing.

DAC acquisition pipeline — Jojo Shaju, Tirhan

Dodged

Won't bid all (low maturity); will explore others. Tender size varies; most exceed Vice Chief's threshold (>₹4-digit Cr). Timeline depends on AON approval.

Export and certification — Tushar Khurana, Peace Wealth

Partial

Tracking LC-ISR challenge; participating if suitable. Blue SUAS certification process ongoing, very involved.

Partnership strategy — Midhun James, Moat PMS

Answered

4 investments in entities: Nautical Wings (carbon fiber propeller supplier); GalaxEye (drone-borne radar); TEHEAGLE (FTP platforms). Exploring technical collaboration and downstream opportunities.

Guidance

Forward guidance and management's confidence

No explicit FY27 revenue target stated

Low

Management focuses on order book execution (₹202.2 Cr remaining) and FTP pipeline conversions without quantifying expected revenue

Gross margin 50-55% (from Q1 guidance, reaffirmed implicitly)

High

Q2 delivered 54.3%, tracking center of range. Dependent on product mix (defense vs civil)

EBITDA margin ~25% (implied from Q2: 25.4%)

Medium

Supported by Q2 execution; subject to operating leverage and product mix

₹80-90 Cr annually under RDI funding for YETI, ZOLT, and platform development

High

₹151 Cr debt + company matching; committed for ~10 years; split across R&D, capex, working capital

Risks the call surfaced

Ranked by how much they should concern a holder

Order book replenishment

Medium

Order book fell ₹54.6 Cr (21% QoQ) to ₹202.2 Cr after Q2; execution pace insufficient to maintain 200%+ growth if FTP pipeline doesn't convert in H2 FY27

FTP pipeline timing

High

₹20,000+ Cr fast-track opportunities fragmented and largely in approval/evaluation stages; no firm RFP timelines or conversion probabilities disclosed

Supply chain constraints

Medium

Management acknowledges 'persistent global supply chain constraints' and 'certain delays in customer approvals for deliveries'; could constrain H2 execution of ₹202.2 Cr order book

Product development timelines

Medium

ZOLT Hybrid, YETI, and combat UAV variants still in development/field trial phases; scale-up timelines extend into FY28; commercialization uncertainty

Export certification delays

Low

Blue SUAS certification and NATO compliance pathways lengthy and uncertain; delays could gate international (US, NATO, Canada) revenue inflows

Management

Score 7/10. CEO articulate and detailed on technology roadmap (ZOLT, YETI, SWITCH, electronic warfare). However, evasive on product mix breakdown, FTP quantum, and order inflow timelines. CFO transparent on financial mechanics (RDI terms, capex deployment) but vague on future order conversions. Delivered strong Q2 (₹91.3 Cr, +124% YoY) and H1 (₹159.9 Cr, +200% YoY). Gross margin tracking guidance (50-55%, now 54.3%). BUT order book replenishment pace slower than prior implied; execution of ₹256.8 Cr order book extending beyond Q3. Return to profitability (+133% YoY PAT) achieved.

What to watch next
  • 1 · Q3-Q4 FY27

    FTP procurement RFPs expected to convert; DAC approvals recently cleared

  • 2 · FY28

    ZOLT Hybrid field trials and commercialization; YETI platform milestones with ₹151 Cr RDI support

  • 3 · H2 FY27

    Execution of ₹202.2 Cr remaining order book; fresh order inflows critical to offset depletion

Large ₹20,000+ Cr fast-track procurement pipeline remains in early approval stages with no firm timelines; absence of forward guidance limits conviction.

Informational and educational content only. Not investment advice.